NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Akela Pharma Inc. 

3333 Côte Vertu
Suite 710
St-Laurent  Quebec  H4R 2N1  Canada
Phone: 514-315-3330 Fax: 514-315-3325


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Akela Pharma Inc. and PharmaForm LLC Expand Drug Formulation and Manufacturing Capabilities 11/4/2009 12:12:54 PM    More...
Akela Pharma Inc. to Cut Staff by 33 Percent, to Close Sites 9/3/2009 6:41:17 AM    More...
Akela Pharma Inc. Announces New CEO 9/2/2009 6:45:01 AM    More...
Akela Pharma Inc. Appoints New Board of Directors 6/26/2009 11:43:52 AM    More...
Akela Pharma Inc. and Nventa Biopharmaceuticals Corporation (NVN.TO) Announce Closing of Merger 5/22/2009 7:08:44 AM    More...
Akela Pharma Inc. to Buy Nventa Biopharmaceuticals Corporation (NVN.TO) in Stock Deal Worth C $1.4 Million 3/27/2009 7:10:50 AM    More...
Akela Pharma Inc. to Cut Costs to Sustain Long-Term Viability of the Company 2/9/2009 6:41:16 AM    More...
Akela Pharma Inc. Announces Achievement of Third Fentanyl TAIFUN(R) Phase 3 Study Related Milestone 1/13/2009 10:43:10 AM    More...
Akela Pharma Inc. Reports Results for the Third Quarter of Fiscal 2008 11/14/2008 4:33:43 PM    More...
Akela Pharma Inc. Announces Approval to Initiate Fentanyl TAIFUN(R) Phase 3 Study in Europe and Initiation of Clinical Program in Japan 9/4/2008 3:04:19 PM    More...
1234